• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.人体测量学指标对 Dunnigan 型家族性部分性脂肪营养不良的诊断价值。
J Clin Endocrinol Metab. 2020 Jul 1;105(7):2132-41. doi: 10.1210/clinem/dgaa137.
2
Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.Dunnigan 型脂肪营养不良相关 LMNA 变异所致儿童区域性体脂变化与代谢并发症。
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1099-1108. doi: 10.1210/jc.2018-01922.
3
Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2.家族性部分性脂肪营养不良 2 型患者的表型多样性和糖皮质激素敏感性。
Clin Endocrinol (Oxf). 2019 Jul;91(1):94-103. doi: 10.1111/cen.13984. Epub 2019 Apr 15.
4
Irisin levels in LMNA-associated partial lipodystrophies.LMNA 相关部分性脂肪营养不良中的鸢尾素水平。
Diabetes Metab. 2019 Jan;45(1):67-75. doi: 10.1016/j.diabet.2018.08.003. Epub 2018 Aug 27.
5
Phenotypic Differences Among Familial Partial Lipodystrophy Due to or Variants.由……或变体导致的家族性部分脂肪营养不良的表型差异。
J Endocr Soc. 2022 Oct 11;6(12):bvac155. doi: 10.1210/jendso/bvac155. eCollection 2022 Oct 26.
6
High-throughput Second-generation Sequencing Technology Assisted Diagnosis of Familial Partial Lipodystrophy (Type 2 Kobberling-Dunnigan Syndrome): A Case Report.高通量第二代测序技术辅助诊断家族性部分性脂肪营养不良(2 型科伯林-邓尼根综合征):病例报告。
Comb Chem High Throughput Screen. 2024;27(2):346-351. doi: 10.2174/1386207326666230523112454.
7
Type 1 familial partial lipodystrophy: understanding the Köbberling syndrome.1型家族性部分脂肪营养不良:认识科贝林综合征。
Endocrine. 2016 Nov;54(2):411-421. doi: 10.1007/s12020-016-1002-x. Epub 2016 Jul 30.
8
Describing the natural history of clinical, biochemical and radiological outcomes of children with familial partial lipodystrophy type 2 (FPLD2) from the United Kingdom: A retrospective case series.描述英国家族性部分脂肪营养不良 2 型(FPLD2)患儿的临床、生化和放射学结局的自然史:一项回顾性病例系列研究。
Clin Endocrinol (Oxf). 2022 Dec;97(6):755-762. doi: 10.1111/cen.14806. Epub 2022 Aug 17.
9
Evaluation of Dietary Intake, Leisure-Time Physical Activity, and Metabolic Profile in Women with Mutation in the LMNA Gene.LMNA基因发生突变的女性的饮食摄入、休闲时间身体活动及代谢特征评估
J Am Coll Nutr. 2017 May-Jun;36(4):248-252. doi: 10.1080/07315724.2016.1262299. Epub 2017 Apr 26.
10
The role of LMNA in adipose: a novel mouse model of lipodystrophy based on the Dunnigan-type familial partial lipodystrophy mutation.LMNA在脂肪组织中的作用:基于邓尼根式家族性部分脂肪营养不良突变的新型脂肪营养不良小鼠模型。
J Lipid Res. 2009 Jun;50(6):1068-79. doi: 10.1194/jlr.M800491-JLR200. Epub 2009 Feb 5.

引用本文的文献

1
Clinical Guidance for Lipodystrophy Syndromes: From Diagnosis and Work-Up to Treatment.脂肪代谢障碍综合征的临床指南:从诊断、检查到治疗
Curr Diab Rep. 2025 Sep 2;25(1):47. doi: 10.1007/s11892-025-01603-4.
2
Brazilian expert consensus on the diagnosis, classification, screening for complications and treatment of familial partial lipodystrophy.巴西关于家族性部分脂肪营养不良的诊断、分类、并发症筛查及治疗的专家共识。
Diabetol Metab Syndr. 2025 Jun 2;17(1):186. doi: 10.1186/s13098-025-01733-5.
3
Diagnosis and Management of Genetic Lipodystrophy Syndromes and its Implications for Atherosclerosis.遗传性脂肪营养不良综合征的诊断与管理及其对动脉粥样硬化的影响
Curr Atheroscler Rep. 2025 May 13;27(1):55. doi: 10.1007/s11883-025-01301-2.
4
A Rare Cause of Acute Pancreatitis: Two Siblings With Werner Syndrome.急性胰腺炎的罕见病因:两名患有沃纳综合征的兄弟姐妹。
JCEM Case Rep. 2025 Apr 10;3(5):luaf061. doi: 10.1210/jcemcr/luaf061. eCollection 2025 May.
5
Gain of Function NOTCH3 Variants Cause Familial Partial Lipodystrophy Due to Activation of Senescence Pathways.功能获得性NOTCH3变体因衰老途径激活导致家族性部分脂肪营养不良。
Diabetes. 2025 Mar 1;74(3):427-438. doi: 10.2337/db24-0624.
6
Phenotypic and molecular reanalysis of a cohort of patients with monogenic diabetes reveals a case of partial lipodystrophy due to the A8344G mutation in the mitochondrial DNA.对一组单基因糖尿病患者进行表型和分子重新分析,揭示了一例由于线粒体 DNA 中的 A8344G 突变导致的部分脂肪营养不良病例。
Arch Endocrinol Metab. 2024 Jun 19;68:e230084. doi: 10.20945/2359-4292-2023-0084. eCollection 2024.
7
Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.人体测量作为女性家族性部分脂肪营养不良的关键诊断工具。
Diabetol Metab Syndr. 2024 Sep 4;16(1):216. doi: 10.1186/s13098-024-01413-w.
8
A rapid action plan to improve diagnosis and management of lipodystrophy syndromes.改善脂肪营养不良综合征的诊断和管理的快速行动计划。
Front Endocrinol (Lausanne). 2024 Jun 4;15:1383318. doi: 10.3389/fendo.2024.1383318. eCollection 2024.
9
Relationship of Fat Mass Ratio, a Biomarker for Lipodystrophy, With Cardiometabolic Traits.脂肪质量比与脂肪营养不良生物标志物的关系及其与心脏代谢特征的关系。
Diabetes. 2024 Jul 1;73(7):1099-1111. doi: 10.2337/db23-0575.
10
Clinical and imaging features of women with polygenic partial lipodystrophy: a case series.多基因部分性脂肪营养不良女性的临床和影像学特征:病例系列。
Nutr Diabetes. 2024 Feb 6;14(1):3. doi: 10.1038/s41387-024-00260-y.

本文引用的文献

1
Comorbidities and Survival in Patients With Lipodystrophy: An International Chart Review Study.脂代谢障碍患者的合并症与生存状况:一项国际性图表回顾研究。
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5120-5135. doi: 10.1210/jc.2018-02730.
2
Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants.PPARG 与 LMNA 致病性变异所致家族性部分脂肪营养不良 metreleptin 治疗的疗效。
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3068-3076. doi: 10.1210/jc.2018-02787.
3
Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease.脂肪营养不良、血脂异常和动脉粥样硬化性心血管疾病。
Pathology. 2019 Feb;51(2):202-212. doi: 10.1016/j.pathol.2018.11.004. Epub 2018 Dec 27.
4
Regional Body Fat Changes and Metabolic Complications in Children With Dunnigan Lipodystrophy-Causing LMNA Variants.Dunnigan 型脂肪营养不良相关 LMNA 变异所致儿童区域性体脂变化与代谢并发症。
J Clin Endocrinol Metab. 2019 Apr 1;104(4):1099-1108. doi: 10.1210/jc.2018-01922.
5
"Fat Shadows" From DXA for the Qualitative Assessment of Lipodystrophy: When a Picture Is Worth a Thousand Numbers.DXA 定量评估脂肪营养不良的“脂肪暗区”:一图胜千数。
Diabetes Care. 2018 Oct;41(10):2255-2258. doi: 10.2337/dc18-0978.
6
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease.一种截短蛋白的HSD17B13变体与慢性肝病的防护
N Engl J Med. 2018 Mar 22;378(12):1096-1106. doi: 10.1056/NEJMoa1712191.
7
Spectrum of disease associated with partial lipodystrophy: lessons from a trial cohort.与部分脂肪营养不良相关的疾病谱:来自一个试验队列的经验教训
Clin Endocrinol (Oxf). 2017 May;86(5):698-707. doi: 10.1111/cen.13311. Epub 2017 Mar 27.
8
Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance.整合基因组分析表明,外周脂肪储存能力有限与人类胰岛素抵抗的发病机制有关。
Nat Genet. 2017 Jan;49(1):17-26. doi: 10.1038/ng.3714. Epub 2016 Nov 14.
9
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.脂肪营养不良综合征的诊断与管理:多学会实践指南
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6.
10
DXA: Technical aspects and application.双能X线吸收测定法:技术方面与应用
Eur J Radiol. 2016 Aug;85(8):1481-92. doi: 10.1016/j.ejrad.2016.04.004. Epub 2016 Apr 14.

人体测量学指标对 Dunnigan 型家族性部分性脂肪营养不良的诊断价值。

Diagnostic Value of Anthropometric Measurements for Familial Partial Lipodystrophy, Dunnigan Variety.

机构信息

The Division of Nutrition and Metabolic Diseases and the Center for Human Nutrition, Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.

Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, Texas.

出版信息

J Clin Endocrinol Metab. 2020 Jul 1;105(7):2132-41. doi: 10.1210/clinem/dgaa137.

DOI:10.1210/clinem/dgaa137
PMID:32193531
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7202860/
Abstract

CONTEXT

Familial partial lipodystrophy, Dunnigan variety (FPLD2) is a rare autosomal dominant disorder resulting from LMNA causal variants, which is characterized by loss of subcutaneous fat from the extremities and predisposition to metabolic complications. The diagnostic value of various anthropometric measurements for FPLD2 remains unknown.

OBJECTIVE

To determine specificity and sensitivity of anthropometric measurements for the diagnosis of FPLD2.

METHODS

We measured skinfold thickness and regional body fat by dual energy X-ray absorptiometry (DXA) in 50 adult females and 6 males with FPLD2 at UT Southwestern and compared their data with the sex- and age-matched controls from the National Health and Nutrition Examination Survey (NHANES) 1999-2010. We further compared data from 1652 unaffected females from the Dallas Heart Study and 23 females with FPLD2 from the National Institutes of Health with the NHANES data.

RESULTS

The DXA-derived lower limb fat (%) had the best specificity (0.995) and sensitivity (1.0) compared with the upper limb fat, truncal fat, the ratio of lower limb to truncal fat, and triceps skinfold thickness for adult females with FPLD2. The lower limb fat below 1st percentile of NHANES females had a false-positive rate of 0.0054 and a false negative rate of 0. The diagnostic value of anthropometric parameters could not be determined for males with FPLD2 due to small sample size.

CONCLUSIONS

The lower limb fat (%) is the best objective anthropometric measure for diagnosing FPLD2 in females. Women with below the 1st percentile lower limb fat should undergo genetic testing for FPLD2, especially if they have metabolic complications.

摘要

背景

家族性部分脂肪营养不良,邓尼根型(FPLD2)是一种罕见的常染色体显性遗传疾病,由 LMNA 致病变异引起,其特征是四肢皮下脂肪丧失,并易发生代谢并发症。各种人体测量学指标对 FPLD2 的诊断价值尚不清楚。

目的

确定人体测量学指标对 FPLD2 诊断的特异性和敏感性。

方法

我们在德克萨斯西南医学中心测量了 50 名成年女性和 6 名男性 FPLD2 患者的皮褶厚度和区域体脂肪,并将其数据与 1999-2010 年国家健康和营养检查调查(NHANES)中性别和年龄匹配的对照组进行比较。我们还将来自达拉斯心脏研究的 1652 名未受影响的女性数据和来自美国国立卫生研究院的 23 名 FPLD2 女性数据与 NHANES 数据进行了比较。

结果

与上肢脂肪、躯干脂肪、下肢与躯干脂肪比和肱三头肌皮褶厚度相比,DXA 衍生的下肢脂肪(%)在女性 FPLD2 患者中具有最佳的特异性(0.995)和敏感性(1.0)。FPLD2 女性的下肢脂肪低于 NHANES 女性第 1 百分位数的假阳性率为 0.0054,假阴性率为 0。由于男性 FPLD2 患者的样本量较小,无法确定人体测量参数的诊断价值。

结论

下肢脂肪(%)是女性 FPLD2 诊断的最佳客观人体测量指标。下肢脂肪低于第 1 百分位数的女性应进行 FPLD2 的基因检测,尤其是如果她们有代谢并发症的话。